<DOC>
	<DOC>NCT00281554</DOC>
	<brief_summary>This study is designed to determine the safety of RSD1235 in patients with atrial fibrillation.</brief_summary>
	<brief_title>Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Subject must have symptomatic AF Subject must have adequate anticoagulant therapy Subject may not have Class IV congestive heart failure. Subject may not have uncorrected electrolyte imbalance.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Investigational Therapies</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Treatment Efficacy</keyword>
	<keyword>Treatment Effectiveness</keyword>
	<keyword>Safety</keyword>
	<keyword>RSD1235</keyword>
</DOC>